UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

DNA methylation based biomarkers in non-invasive cancer screening

Current molecular medicine, 2010-03, Vol.10 (2), p.123-132

2010

Volltextzugriff (PDF)

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Oncogene, 2009-08, Vol.28 (31), p.S24

Gazdar, A.F

2009

Volltextzugriff (PDF)

Should we continue to use the term non-small-cell lung cancer?

Annals of oncology, 2010-10, Vol.21 (suppl-7), p.vii225-vii229

Gazdar, A F

2010

Volltextzugriff (PDF)

Defining Tumor mRNA Expression Signatures Predicting Response of Lung Cancers to Radiation Therapy

International journal of radiation oncology, biology, physics, 2009, Vol.75 (3), p.S558-S558

2009

Volltextzugriff (PDF)

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Oncogene, 2008-06, Vol.27 (25), p.3635-3640

2008

Volltextzugriff (PDF)

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Annals of oncology, 2007-04, Vol.18 (4), p.752-760

2007

Volltextzugriff (PDF)

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

Oncogene, 2013-08, Vol.32 (34), p.4034-4042

2013

Volltextzugriff (PDF)

DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers

Oncogene, 2008-07, Vol.27 (33), p.4615-4624

2008

Volltextzugriff (PDF)

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

Oncogene, 2010-03, Vol.29 (10), p.1421-1430

2010

Volltextzugriff (PDF)

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk

Oncogene, 2014-09, Vol.33 (36), p.4464-4473

2014

Volltextzugriff (PDF)

Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells

Oncogene, 2010-05, Vol.29 (18), p.2616-2627

2010

Volltextzugriff (PDF)

14 Debate: Does SV40 play a causative role in mesothelial cell carcinogenesis? Yes

Lung cancer (Amsterdam, Netherlands), 2006-10, Vol.54, p.S4-S4

Gazdar, A.F.

2006

Volltextzugriff (PDF)

Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection

Oncogene, 2014-05, Vol.33 (21), p.2814

2014

Volltextzugriff (PDF)

Proteomic Analysis of Human Lung Cancer Cell Lines

Annals of oncology, 2012-09, Vol.23, p.ix544

2012

Volltextzugriff (PDF)

1701 - Proteomic Analysis of Human Lung Cancer Cell Lines

Annals of oncology, 2012-09, Vol.23, p.ix544-ix544

2012

Volltextzugriff (PDF)

Association of SV40 with human tumours

Seminars in cancer biology, 2001-02, Vol.11 (1), p.49-61

2001

Volltextzugriff (PDF)

Quantitative Analysis of MDR1 (Multidrug Resistance) Gene Expression in Human Tumors by Polymerase Chain Reaction

Proceedings of the National Academy of Sciences - PNAS, 1990-09, Vol.87 (18), p.7160-7164

1990

Volltextzugriff (PDF)

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer

Cancer research (Chicago, Ill.), 1994-07, Vol.54 (13), p.3387-3390

1994

Volltextzugriff (PDF)

Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system

Human pathology, 1985-11, Vol.16 (11), p.1098-1109

1985

Volltextzugriff (PDF)

Session 7 S23. Key issues in lung cancer chemoprevention trials of new agents

European journal of cancer (1990), 2002-02, Vol.38, p.S26-S26

2002

Volltextzugriff (PDF)

Human Small-Cell Lung Cancers Show Amplification and Expression of the N-myc Gene

Proceedings of the National Academy of Sciences - PNAS, 1986-02, Vol.83 (4), p.1092-1096

1986

Volltextzugriff (PDF)

A histopathologic evaluation of premalignant and early malignant bronchial lesions: An interactive program based on internet digital images to improve WHO criteria for early diagnosis of lung cancer and for monitoring chemoprevention studies—A SPORE collaborative project

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.209-209

2000

Volltextzugriff (PDF)

Balanced translocations involving chromosome 19 p in human lung cancer associated with overexpression of Notch3

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.178-178

2000

Volltextzugriff (PDF)

Frequent occurance of aberrant promoter methylation of either RARβ, TIMP-3, p16, MGMT, FHIT, DAPK, Ecad, p14 or GSTP1 in resected non-small cell lung cancers

Lung cancer (Amsterdam, Netherlands), 2000-09, Vol.29 (1), p.207-207

2000

Volltextzugriff (PDF)

Human Telomerase RNA Expression and MIB-1 (Ki-67) Proliferation Index Distinguish Hemangioblastomas From Metastatic Renal Cell Carcinomas

The Journal of urology, 1998-11, Vol.160 (5), p.1953-1954

1998

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(45)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DNA methylation based biomarkers in non-invasive cancer screening

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Should we continue to use the term non-small-cell lung cancer?

Defining Tumor mRNA Expression Signatures Predicting Response of Lung Cancers to Radiation Therapy

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib

Oncogenic KRAS-induced epiregulin overexpression contributes to aggressive phenotype and is a promising therapeutic target in non-small-cell lung cancer

DNA amplification is a ubiquitous mechanism of oncogene activation in lung and other cancers

Genomic and functional analysis identifies CRKL as an oncogene amplified in lung cancer

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk

Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells

14 Debate: Does SV40 play a causative role in mesothelial cell carcinogenesis? Yes

Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection

Proteomic Analysis of Human Lung Cancer Cell Lines

1701 - Proteomic Analysis of Human Lung Cancer Cell Lines

Association of SV40 with human tumours

Quantitative Analysis of MDR1 (Multidrug Resistance) Gene Expression in Human Tumors by Polymerase Chain Reaction

HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer

Histologic assessment of lymph nodes in mycosis fungoides/sézary syndrome (cutaneous T-cell lymphoma): Clinical correlations and prognostic import of a new classification system

Session 7 S23. Key issues in lung cancer chemoprevention trials of new agents

Human Small-Cell Lung Cancers Show Amplification and Expression of the N-myc Gene

A histopathologic evaluation of premalignant and early malignant bronchial lesions: An interactive program based on internet digital images to improve WHO criteria for early diagnosis of lung cancer and for monitoring chemoprevention studies—A SPORE collaborative project

Balanced translocations involving chromosome 19 p in human lung cancer associated with overexpression of Notch3

Frequent occurance of aberrant promoter methylation of either RARβ, TIMP-3, p16, MGMT, FHIT, DAPK, Ecad, p14 or GSTP1 in resected non-small cell lung cancers

Human Telomerase RNA Expression and MIB-1 (Ki-67) Proliferation Index Distinguish Hemangioblastomas From Metastatic Renal Cell Carcinomas

Suchergebnisse filtern